102 related articles for article (PubMed ID: 6692356)
41. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
Chow FP; Zsebo K; Hamburger AW
Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
[TBL] [Abstract][Full Text] [Related]
42. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
Laterveer L; van Damme J; Willemze R; Fibbe WE
Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
[TBL] [Abstract][Full Text] [Related]
43. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
[TBL] [Abstract][Full Text] [Related]
44. Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD.
Cooper MH; Patrene KD; Vecchini F; Austin CA; Markus PM; Boggs SS
Bone Marrow Transplant; 1994 Sep; 14(3):355-62. PubMed ID: 7527689
[TBL] [Abstract][Full Text] [Related]
45. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
Vadlamudi S; Waravdekar VS; Choudry JN; Goldin A
Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
[No Abstract] [Full Text] [Related]
46. Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy.
Brereton HD; Bryant TL; Young RC
Cancer Res; 1975 Sep; 35(9):2420-5. PubMed ID: 1149044
[TBL] [Abstract][Full Text] [Related]
47. Effect of the nitrosourea derivative rpcnu (ICIG 1163) on the development of Friend leukemia in mice.
Larnicol N; Augery Y; Jasmin C; Montero JL; Imbach JL
Biomedicine; 1977 May; 26(3):176-81. PubMed ID: 890012
[TBL] [Abstract][Full Text] [Related]
48. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
Bedford P; Berger MR; Eisenbrand G; Schmähl D
J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
[TBL] [Abstract][Full Text] [Related]
49. The A.H.E.A.D. method: a quantitative automated measurement of the hematotoxicity of anticancer drugs.
Saint-Dizier D; Sancier M; Cudennec CA
Anticancer Res; 1990; 10(3):765-71. PubMed ID: 2369090
[TBL] [Abstract][Full Text] [Related]
50. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
Aoshima M; Sakurai Y
Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
[TBL] [Abstract][Full Text] [Related]
51. [Dynamics of the chromosomal damages to Ehrlich ascitic cancer and bone marrow cells of mice by the antitumor preparation dimetinur].
Fomina MM; Bogoslovskaia EP; Konradov AA; Ostrovskaia LA
Eksp Onkol; 1986; 8(3):70-4. PubMed ID: 3720644
[TBL] [Abstract][Full Text] [Related]
52. Cytostatic action of two nitrosoureas derived from cysteamine.
Bourut C; Chenu E; Godenèche D; Madelmont JC; Maral R; Mathé G; Meyniel G
Br J Pharmacol; 1986 Nov; 89(3):539-46. PubMed ID: 3801787
[TBL] [Abstract][Full Text] [Related]
53. [Chemotherapeutic characterization of new nitrosourea compounds].
Zeller WJ; Berger MR; Eisenbrand G; Petru E
Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433
[TBL] [Abstract][Full Text] [Related]
54. Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas.
Ahlgren JD; Green DC; Tew KD; Schein PS
Cancer Res; 1982 Jul; 42(7):2605-8. PubMed ID: 6211225
[TBL] [Abstract][Full Text] [Related]
55. More than additive toxicity of the combination of 1-methyl-1-nitrosourea plus 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat.
Zeller WJ; Berger MR; Henne T; Weber E
Cancer Res; 1986 Apr; 46(4 Pt 1):1714-6. PubMed ID: 3948161
[TBL] [Abstract][Full Text] [Related]
56. Residual toxicity in hematopoietic cells following a single dose of methylnitrosourea.
Inoue T; Cronkite EP; Commerford SL; Carsten AL
Leuk Res; 1984; 8(1):105-16. PubMed ID: 6700258
[TBL] [Abstract][Full Text] [Related]
57. [Effect of nitrosomethylurea (NMU) on the growth kinetics and protein biosynthesis in leukemia L1210 cells].
Kukushkina GV; Sokolova IS; Ostrovskaia LA; Gorbacheva LB
Izv Akad Nauk SSSR Biol; 1972; 5():731-6. PubMed ID: 4667390
[No Abstract] [Full Text] [Related]
58. Lethal toxicity and myelotoxicity to mice of the combination of 6-thioguanine and 3-[(4-amine-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):667-73. PubMed ID: 6939646
[TBL] [Abstract][Full Text] [Related]
59. Megakaryocyte expansion and macrophage infiltration in bone marrow of rats subchronically treated with MNX, N-nitroso environmental degradation product of munitions compound RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine).
Ramasahayam S; Jaligama S; Atwa SM; Salley JT; Thongdy M; Blaylock BL; Meyer SA
J Appl Toxicol; 2017 Aug; 37(8):913-921. PubMed ID: 28138994
[TBL] [Abstract][Full Text] [Related]
60. Toxicology and pharmacology of the nitrosoureas.
Oliverio VT
Cancer Chemother Rep 3; 1973 May; 4(3):13-20. PubMed ID: 4201308
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
